BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/7/2014 4:46:00 PM | Browse: 776 | Download: 1467
| Category |
Andrology |
| Manuscript Type |
Review |
| Article Title |
Chronic kidney disease and erectile dysfunction
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Etsu Suzuki, Hiroaki Nishimatsu, Shigeyoshi Oba, Masao Takahashi and Yukio Homma |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Etsu Suzuki, MD, PhD, Institute of Medical Science, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki 216-8512, Japan. esuzuki-tky@umin.ac.jp |
| Key Words |
Erectile dysfunction; Chronic kidney disease; Nitric oxide; Phosphodiesterase type 5; Testosterone |
| Core Tip |
Erectile dysfunction (ED) is a common condition in chronic kidney disease (CKD) patients. The etiology is multifactorial. Phosphodiesterase type 5 inhibitors are commonly used for the initial treatment. ED has gained attention as an early marker for cardiovascular disease (CVD), which it frequently precedes. Therefore, it is pivotal to examine the presence of ED in CKD patients not only for the improvement of quality of life but also for the prevention of CVD attack. The pathophysiology of erection, which most nephrologists are not familiar with, is also discussed. |
| Publish Date |
2014-11-07 16:40 |
| Citation |
Suzuki E, Nishimatsu H, Oba S, Takahashi M, Homma Y. Chronic kidney disease and erectile dysfunction. World J Nephrol 2014; 3(4): 220-229
|
| URL |
http://www.wjgnet.com/2220-6124/full/v3/i4/220.htm |
| DOI |
http://dx.doi.org/10.5527/wjn.v3.i4.220 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.